283 related articles for article (PubMed ID: 25267662)
21. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
22. Colistin in critically ill patients.
Boisson M; Gregoire N; Couet W; Mimoz O
Minerva Anestesiol; 2013 Feb; 79(2):200-8. PubMed ID: 23241733
[TBL] [Abstract][Full Text] [Related]
23. Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.
Leuppi-Taegtmeyer AB; Decosterd L; Osthoff M; Mueller NJ; Buclin T; Corti N
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478168
[TBL] [Abstract][Full Text] [Related]
24. Optimizing colistin dosing: Is a loading dose necessary?
Nazer LH; Anabtawi N
Am J Health Syst Pharm; 2017 Jan; 74(1):e9-e16. PubMed ID: 28007716
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections.
Ni M; Zhao L; Zhang WJ; Ma JW; Zhang GY; Cui DM; Wang K; Fei YB; Gao L; Shen FM
Int J Antimicrob Agents; 2021 Mar; 57(3):106281. PubMed ID: 33465459
[TBL] [Abstract][Full Text] [Related]
26. Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.
Karaiskos I; Friberg LE; Galani L; Ioannidis K; Katsouda E; Athanassa Z; Paskalis H; Giamarellou H
Int J Antimicrob Agents; 2016 Sep; 48(3):337-41. PubMed ID: 27474468
[TBL] [Abstract][Full Text] [Related]
27. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
[TBL] [Abstract][Full Text] [Related]
28. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
Zavascki AP
Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate.
Imberti R; Cusato M; Accetta G; Marinò V; Procaccio F; Del Gaudio A; Iotti GA; Regazzi M
Antimicrob Agents Chemother; 2012 Aug; 56(8):4416-21. PubMed ID: 22687507
[TBL] [Abstract][Full Text] [Related]
30. [Shedding light on the use of colistin: still gaps to be filled].
Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179
[TBL] [Abstract][Full Text] [Related]
32. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
33. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
[TBL] [Abstract][Full Text] [Related]
34. Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy.
Schmidt JJ; Strunk AK; David S; Bode-Böger SM; Martens-Lobenhoffer J; Knitsch W; Scherneck S; Welte T; Kielstein JT
J Antimicrob Chemother; 2019 Apr; 74(4):997-1002. PubMed ID: 30624668
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series.
Trifi A; Abdellatif S; Daly F; Mahjoub K; Nasri R; Oueslati M; Mannai R; Bouzidi M; Ben Lakhal S
Chemotherapy; 2016; 61(4):190-6. PubMed ID: 26863534
[TBL] [Abstract][Full Text] [Related]
36. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
Dalfino L; Puntillo F; Mosca A; Monno R; Spada ML; Coppolecchia S; Miragliotta G; Bruno F; Brienza N
Clin Infect Dis; 2012 Jun; 54(12):1720-6. PubMed ID: 22423120
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of colistin methanesulfonate sodium in correlation with pharmacokinetic parameters in critically ill patients with multi-drug resistant bacteria-mediated infection: A systematic review and meta-analysis.
Son JY; Kim S; Porsuk T; Shin S; Choi YJ
J Infect Public Health; 2024 May; 17(5):843-853. PubMed ID: 38554590
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections.
Kim EJ; Oh J; Lee K; Yu KS; Chung JY; Hwang JH; Nam EY; Kim HS; Kim M; Park JS; Song KH; Kim ES; Song J; Kim HB
Ther Drug Monit; 2019 Feb; 41(1):102-106. PubMed ID: 30299430
[TBL] [Abstract][Full Text] [Related]
39. Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
Gibson GA; Bauer SR; Neuner EA; Bass SN; Lam SW
Antimicrob Agents Chemother; 2016 Jan; 60(1):431-6. PubMed ID: 26525802
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic evaluation of colistin sodium.
Michalopoulos AS; Karatza DC; Gregorakos L
Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
